Inhibitors of the Glyoxylate Cycle Enzyme ICL1 in Candida albicans for Potential Use as Antifungal Agents
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Candida albicans is an opportunistic pathogen that causes candidiasis in humans. In recent years, metabolic pathways in C. albicans have been explored as potential antifungal targets to treat candidiasis. The glyoxylate cycle, which enables C. albicans to survive in nutrient-limited host niches and its. Key enzymes (e.g., isocitrate lyase (ICL1), are particularly attractive antifungal targets for C. albicans. In this study, we used a new screening approach that better reflects the physiological environment that C. albicans cells experience during infection to identify potential inhibitors of ICL. Three compounds (caffeic acid (CAFF), rosmarinic acid (ROS), and apigenin (API)) were found to have antifungal activity against C. albicans when tested under glucose-depleted conditions. We further confirmed the inhibitory potential of these compounds against ICL using the ICL enzyme assay. Lastly, we assessed the bioavailability and toxicity of these compounds using Lipinski's rule-of-five and ADMET analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 3×
“They are usually benign but can become infectious if an environmental niche becomes available or the host immune system becomes impaired [2].”
BackgroundCandida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848 · cited 3×
“albicans not only contributes to adaptation and survival in host niches but also affects pathogenicity and virulence [4,8].”
BackgroundEpidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
The glyoxylate cycle is required for fungal virulence
Lorenz, M. C., & Fink, G. R. (2001) · Nature · doi:10.1038/35083594 · Cited by 745
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
Perlroth, J., Choi, B., & Spellberg, B. (2007) · Medical Mycology · doi:10.1080/13693780701218689 · Cited by 738 · cited 2×
“Candidiasis is among the most common nosocomial systemic infections, with mortality rates as high as 50% [1,3,4].”
BackgroundEne, I. V., Adya, A. K., Wehmeier, S., Brand, A. C., MacCallum, D. M., Gow, N. A. R., & Brown, A. J. P. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01813.x · Cited by 313
Life and death in a macrophage: role of the glyoxylate cycle in virulence
Lorenz, M. C., & Fink, G. R. (2002) · Eukaryotic Cell · doi:10.1128/ec.1.5.657-662.2002 · Cited by 300
Stage‐specific gene expression of Candida albicans in human blood
Fradin, C., Kretschmar, M., Nichterlein, T., Gaillardin, C., D’Enfert, C., & Hube, B. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03396.x · Cited by 226 · cited 1×
“albicans is activated when cells are engulfed by macrophages and neutrophils [14,15,16,17].”
BackgroundVan Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., Riccardi, G., Boon, N., Nelis, H. J., Mahenthiralingam, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058943 · Cited by 135
Fungal metabolism in host niches
Brock, M. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.05.004 · Cited by 115 · cited 1×
“albicans and other pathogenic fungi for survival in nutrient-limited host niches as it contributes to effective assimilation of different carbon sources [7].”
Background
Cited by
The antifungal pipeline: a reality check
Perfect, J. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.46 · Cited by 866
Potential Use of Phenolic Acids as Anti-Candida Agents: A Review
Teodoro, G. R., Ellepola, K., Seneviratne, C. J., & Koga-Ito, C. Y. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01420 · Cited by 204
“…Planktonic cells of C. albicans and inhibition of isocitrate lyase activity assay MIC (μg/ml): 1000; inhibition of 91,5% of the isocitrate lyase enzyme activity Cheah et al., 2014 Planktonic cells and biofilm of C. albicans (ATCC 10231) MIC (μg/ml): planktonic: 128; pre-formed, 4 and 24 h…”
BackgroundMethodMechanism of Candida pathogenesis: Revisiting the vital drivers
Mba, I. E., & Nweze, E. I. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03912-w · Cited by 143
Rosmarinic acid–Modes of antimicrobial and antibiofilm activities of a common plant polyphenol
Ivanov, M., Kostić, M., Stojković, D., & Soković, M. (2022) · South African Journal of Botany · doi:10.1016/j.sajb.2021.11.050 · Cited by 98
Childers, D. S., Raziunaite, I., Mol Avelar, G., Mackie, J., Budge, S., Stead, D., Gow, N. A. R., Lenardon, M. D., Ballou, E. R., MacCallum, D. M., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005566 · Cited by 81
“This supports the idea that isocitrate lyase represents a potential target for therapeutic intervention [49, 50] as the glyoxylate cycle is not conserved in mammalian cells.”
Background
Metadata
- Authors
- Cheah, H.-L., Lim, V., & Sandai, D.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-04-29
- Volume
- 9
- Issue
- 4
- Pages
- e95951
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2093914439
- Cited by
- 102
- References
- 12
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibitors of the Glyoxylate Cycle Enzyme ICL1 in Candida albicans for Potential Use as Antifungal Agents. https://app.cochat.ai/papers/10.1371/journal.pone.0095951
- The paper
- Cheah, H.-L., Lim, V., & Sandai, D. (2014). Inhibitors of the Glyoxylate Cycle Enzyme ICL1 in Candida albicans for Potential Use as Antifungal Agents. PLoS ONE. https://doi.org/10.1371/journal.pone.0095951
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.